EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allo-Hemodialysis, a Novel Dialytic Treatment Option for Patients with Kidney Failure: Outcomes of Mathematical Modelling, Prototyping, and Ex Vivo Testing

Vaibhav Maheshwari, Nadja Grobe iD, Xin Wang, Amrish Patel, Alhaji Cherif, Xia Tao, Joshua Chao, Alexander Heide, Dejan Nikolic, Jiaming Dong, Peter Kotanko iD

Toxins · 26.06.2024 · 16 (7) · 292

DOI: 10.3390/toxins16070292 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, online erschienen am 26.06.2024. Verfasst von Vaibhav Maheshwari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, 315 East 62nd Street, 3rd Floor, New York, NY 10065, USA. Hauptthemen laut MEDLINE: Renal Dialysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Renal Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It has been estimated that in 2010, over two million patients with end-stage kidney disease may have faced premature death due to a lack of access to affordable renal replacement therapy, mostly dialysis. To address this shortfall in dialytic kidney replacement therapy, we propose a novel, cost-effective, and low-complexity hemodialysis method called allo-hemodialysis (alloHD). With alloHD, instead of conventional hemodialysis, the blood of a patient with kidney failure flows through the dialyzer’s dialysate compartment counter-currently to the blood of a healthy subject (referred to as a “buddy”) flowing through the blood compartment. Along the concentration and hydrostatic pressure gradients, uremic solutes and excess fluid are transferred from the patient to the buddy and subsequently excreted by the healthy kidneys of the buddy. We developed a mathematical model of alloHD to systematically explore dialysis adequacy in terms of weekly standard urea Kt/V. We showed that in the case of an anuric child (20 kg), four 4 h alloHD sessions are sufficient to attain a weekly standard Kt/V of >2.0. In the case of an anuric adult patient (70 kg), six 4 h alloHD sessions are necessary. As a next step, we designed and built an alloHD machine prototype that comprises off-the-shelf components. We then used this prototype to perform ex vivo experiments to investigate the transport of solutes, including urea, creatinine, and protein-bound uremic retention products, and to quantitate the accuracy and precision of the machine’s ultrafiltration control. These experiments showed that alloHD performed as expected, encouraging future in vivo studies in animals with and without kidney failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisHumansChildAnuriaKidney Failure, ChronicUreaModels, TheoreticalMaleAdultRenal Insufficiency

Stichwörter der Autor:innen

acid–base dynamicsallo-hemodialysisalloHDhemodialysisurea kinetic modeling

Substanzen

Urea

Autor:innen und Institutionen

  • Renal Research Institute, 315 East 62nd Street, 3rd Floor, New York, NY 10065, USA.
  • Fresenius Medical Care, 61352 Bad Homburg, Germany.
  • Fresenius Medical Care, Shanghai 200030, China.
  • Icahn School of Medicine at Mount Sinai, New York, NY 10128, USA.

ORCID-Profile: Nadja Grobe, Peter Kotanko

Förderung

  • Renal Research Institute

Zitieren

APA

Maheshwari, V., Grobe, N., Wang, X., Patel, A., Cherif, A., Tao, X., Chao, J., Heide, A., Nikolic, D., Dong, J., & Kotanko, P. (2024). Allo-Hemodialysis, a Novel Dialytic Treatment Option for Patients with Kidney Failure: Outcomes of Mathematical Modelling, Prototyping, and Ex Vivo Testing. Toxins, 16(7), 292. https://doi.org/10.3390/toxins16070292

Vancouver

Maheshwari V, Grobe N, Wang X, Patel A, Cherif A, Tao X, et al. Allo-Hemodialysis, a Novel Dialytic Treatment Option for Patients with Kidney Failure: Outcomes of Mathematical Modelling, Prototyping, and Ex Vivo Testing. Toxins. 2024;16(7):292. doi:10.3390/toxins16070292

BibTeX
@article{Maheshwari2024,
  author = {Maheshwari, Vaibhav and Grobe, Nadja and Wang, Xin and Patel, Amrish and Cherif, Alhaji and Tao, Xia and Chao, Joshua and Heide, Alexander and Nikolic, Dejan and Dong, Jiaming and Kotanko, Peter},
  title = {Allo-Hemodialysis, a Novel Dialytic Treatment Option for Patients with Kidney Failure: Outcomes of Mathematical Modelling, Prototyping, and Ex Vivo Testing},
  journal = {Toxins},
  year = {2024},
  volume = {16},
  number = {7},
  pages = {292},
  doi = {10.3390/toxins16070292}
}
Kostenlos starten →